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Abstract
Robotic mechanisms promise to enhance the diagnostic abilities of capsule endo-
scopes, endow them with novel interventional capabilities and reduce the invasive-
ness of endoscopy. The success of traditional endoscopy in diagnosing disease of the
gastrointestinal (GI) tract can be attributed to the clear view that such techniques
provide of the intestinal lumen and the range of motion they are capable of displaying.
When viewed in the context of capsule endoscopy, the ability to clearly view tissue
and navigate within the GI track both depend on the ability to distend tissue. In an
effort to bring this functionality to wireless capsule endoscopy, the present investiga-
tion examines the feasibility of generating a significant volume of gas from a capsule
based-platform. Success of the system is determined by its ability to provide a level
of insuﬄation that is necessary to enhance visualization, and allow for magnetic lo-
comotion, within the colon. As such, this research begins by quantifying the amount
of gas that must be introduced to the colon to enhance visualization and magnetic
locomotion. Once the desired level of insuﬄation is established, various chemical
reactions are evaluated for use as a gas generator within capsule-based devices. Fi-
nally, prototypes are designed, fabricated and tested to demonstrate the feasibility of
wireless capsule insuﬄation.
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Chapter 1
Introduction
1.1 Motivation
Wireless capsule insuﬄation (WCI) is an enabling technology poised to greatly en-
hance a number of Wireless Capsule Endoscopy (WCE) functions. Research groups
in industry and academia have demonstrated the feasibility of enhanced diagnostic
and interventional WCE platforms. However, reports of such work often fail to ac-
knowledge the need for, or potential benefits provided by, insuﬄation. The present
work looks to prove the feasibility of WCI in an effort to help advance the field of
WCE. While WCI holds the potential to greatly impact wireless locomotion, and
hence allow for advancement of almost all aspects of WCE, this work focuses on its
potential impact on Colorectal Cancer Screening (CRC).
The sections that follow outline the supporting role WCI will play in WCE as
a whole, and CRC screening in particular. A review of the current state of the
art, with respect to WCE and CRC screening, is presented. Preliminary efforts to
assess the levels of insuﬄation necessary to enhance visualization and allow for active
magnetic-based locomotion are documented. Two potential strategies for developing
the necessary gas are demonstrated and concept feasibility is exhibited in an ex-vivo
porcine model.
1
1.1.1 Role as an Enabling Technology for Wireless
Capsule Endoscopy
While little has changed with semi-flexible endoscopes since they were first made
possible by the introduction of glass fibers in 1957, [1] a great deal of effort has
been but forth on the development of accessories for endoscopes. Through the use of
the endoscope’s accessory port, physicians can deploy spectroscopy-based diagnostic
measures [2], deliver hemostasis-promoting therapies [3], take biopsies, or remove
large volumes of tissue including precancourse polyops or advanced carcinomas. In
an effort to advance the field of WCE, researchers throughout the world are working
to develop many of these same capabilities on-board capsule-based platforms (for
example, capsule-based spectroscopy [4], capsule-based delivery of clips for hemostasis
[5] and capsule-based biopsy [6], [7]). And while many of these modalities have been
proven feasible in a single-capsule or multi-capsule platform, their implementation
often requires (or at least would benefit from) the ability to insuﬄate the intestine.
At a fundamental level, the ability to inflate the intestine makes an endoscopist’s
job much easier. Rather than navigate through, and operate within, the compliant
folds of the large intestine, the ability to distend tissue through the use of a pressur-
ized gas or liquid provides the endoscopist with an enhanced view the endoscope’s
surroundings and a greater ability to move within said surroundings. In an effort to
provide this same ease of motion and enhanced visualization to WCE, the present in-
vestigation looks to develop a capsule-based platform that, when remotely activated,
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can deliver a volume of gas sufficient for enhancing local visualization and freedom of
movement.
While the technology presented in this work looks to improve many aspects of
capsule endoscopy, its technological, societal and financial impact are likely to be
most warmly received initially by the colorectal cancer screening community. To that
end, the subsequent section outlines the motivational role which advancing colorectal
cancer (CRC) screening technology plays in the development of this work.
1.1.2 Potential Impact on CRC Screening
Colorectal cancer (CRC) is a proven killer that affects one in five Americans [8]. In
2012 alone, CRC is expected to take the lives of 51,690 Americans [8]. The good
news is findings from a long-term multi-institution study (The American Cancer
Society, the Centers for Disease Control and Prevention (CDC), the National Cancer
Institute (NCI) and the North American Association of Central Cancer Registries
(NAACCR)) shows that the incidence of CRC has been on a steady decline for both
men and women over the last two decades [9]. In an effort to uncover the reason for
this trend Edward et al. [9] preformed rigorous statistical modeling and analysis of
data spanning over three decades. While their data clearly shows a 30% decrease in
CRC incidence over the period from 1985 to 2000, their statical modeling suggests
approximately half of that decline can be attributed to increased screening and its
allowing for early intervention, while the other half is the likely result of increased
knowledge of the risk factors associated with CRC (e.g. smoking [10] , obesity [11],
red meat consumption [12], low aspirin use [13], vitamin deficiencies [14] and physical
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inactivity [10]).
The contributions that patient knowledge provided in reducing CRC incidence
are certainly significant, however, the contributions provided by increased compliance
with screening guidelines serve as a prime motivator behind many of the advancements
in endoscopy that have been seen over the last decade. The American Cancer Society
reports a 5-year survival rate for stage IV CRC of just 6% and a 74% survival rate
for stage I diagnoses, when symptoms are often not apparent [15]. With numbers like
these, and only roughly a third of Americans adhering to recommended CRC screening
guidelines [9, 16], one can easily extrapolate the lack of compliance with suggested
screening guidelines is a likely result of the invasive, and often painful, nature of
current screening methods. This is an assumption that researchers are proving valid
[17]. While devices like PillCamTMCOLON look to mitigate the deterrents to CRC
screening by providing a minimally invasive method for imaging the interior lining of
the colon, current capsule-based colonoscopy techniques suffer from low sensitivity in
the detection of even advanced neoplasia [18]. Such results often occur when a lesion
is hidden from the camera’s view by folds in the intestinal tissue. During traditional
colonoscopy, such lesion are brought into view by inflating the colon to unfurl folds.
However, to date, capsule endoscopy lacks the ability to provide insuﬄation.
1.2 Current State of the Art: CRC Screening
Current protocols for CRC screening vary depending on age, risk factors and advising
agency. As an example, The Center for Disease Control and Prevention (CDC) sug-
gests men and women between the ages of 50-75 be screened using High-Sensitivity
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Fecal Occult Blood Testing (FOBT) each year, flexible sigmoidoscopy every five years,
or colonoscopy every ten years [19]. Alternatively, the American Society for Gas-
trointestinal Endoscopy suggests a preferred modality of colonoscopy every ten years,
but also list alternatives consisting of yearly FOBT and sigmoidoscopy every five
years [20]. Though opinions on screening guidelines may vary, there is wide con-
sensus among physicians and researchers that traditional colonoscopy remains the
gold standard for preforming CRC screenings. Endoscopy-based colonoscopy is often
preferred by physicians, and its use supported in the literature, due to the versatile
diagnostic and therapeutic capability. Despite the stellar reputation that colonoscopy-
based CRC screening has earned, studies have shown that patients are half as likely
to keep a scheduled CRC screening appointment if they know they are going to re-
ceive a traditional colonoscopy when compared to minimally invasive screenings like
(FOBT) [17].
In recent years, the quest to develop less invasive screening methods has fueled ad-
vancements in FOBT, virtual colonoscopy (VC) and capsule-based endoscopy (CE).
While the use of FOBT as a screening modality has received relatively widespread
acceptance, VC remains a cutting-edge technology that is not often utilized and CE
still seeks to prove its capacity to evaluate the colon. In what follows, the strengths
and weakness of the above-mentioned screening methods are discussed.
5
1.2.1 Flexible Sigmoidoscopy
Flexible sigmoidoscopy is similar to colonoscopy but allows the physician to inspect up
to the sigmoid colon whereas colonoscopy allows the physician to evaluate the entire
colon. When compared with colonoscopy, sigmoidoscopy enjoys improved safety (rate
of perforation of 4/25,000 vs 14/25,000) and a lower cost [21]. Like colonoscopy,
flexible sigmoidoscopy is invasive; however, sedition is often not required. While a
number of advisory organizations still list flexible sigmoidoscopy as an option for
cancer screening, a growing number of physicians are acknowledging that its use as a
CRC screening modality may be outdated [22].
1.2.2 Fecal occult-blood testing
Fecal occult-blood testing (FOBT) is a general term used to describe a range of
diagnostic tools which are based on testing a patient’s stool for the presence of blood.
More specifically, the two main commercial FOBT technologies detect two different
classes of hemoglobin products in feces. Guaiac FOBT (gFOBT) detects heme while
fecal immunochemcial test (FIT) detects globin. Based on the underlying principles
of gFOBT, this method of FOBT is not selective for bleeding originating in the colon
and rectum alone. gFOBT is also prone to false-positives that can result from the
consumption of certain fruits and vegetables, as well as aspirin. False-negative results
have also been linked to antioxidants such as vitamin C [21]. Alternatively, FIT is not
subject to interference from drug and dietary selection [23]. Since globin is rapidly
digested in the stomach and small intestine, FIT is much more selective than gFOBT
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when it comes to detecting occult bleeding of colorectal origin. Whether it be gFOBT
or FIT, FOBT simply provides a method for identifying individuals that should be
refereed for colonoscopy and of providing said individuals with compelling evidence
for following through with colonoscopy [23].
1.2.3 Virtual Colonoscopy
While FOBT can provide physicians within an indication as to whether further investi-
gation of a patient’s GI tract is warranted, virtual colonoscopy provides the clinician
with a method for visually inspecting the GI tract. This visual inspection is con-
ducted using a virtual 3D representation generated from computerized tomography
(CT) or magnetic resonance imaging (MRI) data. During a typical procedure, the
patient begins by taking a colon preparation identical to that used during traditional
colonoscopy. The patient is then placed in a CT or MRI system and their colon is
inflated using approximately 3L of room air or carbon dioxide. The imaging system
is then used to scan the patients abdomen in order to generate the 3D rendering of
the colon.
In principle, VC offers the ability to inspect the colon in a non-invasive manner.
In practice, VC requires the use of insuﬄation to provide clear images; hence, while
VC offers the promise of non-invasive imaging of a patent’s GI tract, the actual
implementation of VC still requires the invasive introduction of an air line in order
to provide insuﬄation. The use of insuﬄation has been found to result in perforation
of the colon in a small percentage of patients (< 1%) [24]. Furthermore, the use of
CT or MRI data to construct a virtual rendering of a patient’s GI tract renders this
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technique relatively expensive when compared to alternative screening methods [25].
Also, the use of advanced imaging modalities often reveals extracolonic or incidental
abnormalities which must then be investigated, further adding to the cost associated
with using VC as a CRC screening modality.
1.2.4 Capsule Endoscopy
Similarly to VC, capsule endoscopy (CE) allows a physician to view the interior
lining of a patient’s colon. However, in the case of CE, the physician’s view of the
colon consists of thousands of still images taken from a camera embedded within
a swallowable capsule. This imaging technique not only results in sharper image
quality with respect to VC, it also holds promise for providing physicians with a
real-time method for exploring the colon. Since WCE was first introduced by Given
Imaging Inc. in 2000, more than one million capsules have been used by patients
(per press releases from Given Imaging, Inc.). While this technology has certainly
been well received by patients and physicians alike, commercially available capsule
endoscopes currently only serve as passive observers as they travel through the GI
tract while being propelled by peristalsis. A growing body of research is showing how
these devices might one day allow physicians to precisely control the position and
orientation of capsule endoscopes and even provide therapeutic capabilities.
Commercial entities including Given Imaging, Olympus and Philips have all made
recent attempts to develop capsule-based methods for reliably preforming capsule-
based colonoscopy. To date, their efforts have included methods for actively control-
ling the location and pose of the capsule and adding additional cameras to a capsule
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to provide increased likelihood of capturing clinically-relevant images. Such efforts
have resulted in a capsule (PillCamTMCOLON) that has sought FDA approval as a
screening method for CRC; however, a recent report in the New England Journal of
Medicine shows that PillCamTMCOLON suffers from a high false-negative rate [26].
One reason for the false-negative rate in PillCamTMCOLON has been attributed to its
inability to visualize sites of interest that are obscured by folds in the colon lining [7].
Hence, a logical step in reducing false-negative rates may be the development of a
wireless insuﬄation platform that could be used to enhance visualization in wireless
capsule colonoscopy.
1.3 Thesis Contributions
A method of wireless insuﬄation for use in minimally invasive endoscopy:
The following work provides an assessment of the feasibility of wireless capsule-based
insuﬄation. Wireless insuﬄation looks to enhance wireless capsule endoscopy by en-
hancing visualization and, in the case of magnetic locomotion, enhancing mobility.
In order to make a case of the feasibility of WCI, experiments are conducted to de-
termine the amount of gas required to enhance visualization within the colon and
allow for magnetic locomotion. The design of wireless insuﬄation capsules having
dimensions on par with that of commercially available capsule are presented. Proto-
types of said capsules are constructed and feasibility of wireless capsule insuﬄation
is demonstrated in an ex-vivo model.
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Chapter 2
Functional Requirements
This chapter establishes insuﬄation levels that are required for enhancing visualiza-
tion of, and locomotion through, the colon during WCE. Experimental results are
presented which look to quantify the amount of gas needed to enhance visualization
and locomotion. This data is required to assess the feasibility of delivering a sufficient
amount of gas from a given capsule with a given chemical reaction. This data is also
needed to inform the design process described later in this thesis.
2.1 Need for Establishing Functional Requirements
One common challenge all endoscopic capsules must contend with is the distention
of tissue away from the device, and particularly away from the face of the on-board
camera (see Figure 2.1 (a)). This is especially important in the large intestine, where
the intestinal lumen is much larger than the capsule diameter. Traditional endoscopes
achieve distention by inflating the intestine with air. Such insuﬄation provides a much
clearer view of the wall of the intestine, as can be seen in Figure 2.1 (b). It should
be noted, however, that insufllation is not without drawbacks. Inflation can cause
moderate to severe pain [27] and use of the wrong insuﬄating medium can result in
disastrous and, at times explosive [19], consequences. While room air is commonly
used as an insuﬄating medium, carbon dioxide [27, 28], helium [29] and water [30]
have also been investigated as distending mediums.
In a 2004 study presented by Burling at el., researchers found that, when using
an automated CO2 delivery system with pressure-based closed-loop control during
10
(a) (b) (c)
Figure 2.1: (a) An image from a colonoscope of the colon prior to insuﬄation. (b) An
image after insuﬄation. Note that in this image much more of the intestinal surface
can be seen. Also pictured here is a prototype of a capsule robot with legs [31].(c)
An image showing a capsule controlled by external magnetic fields (e.g. [32]) that has
difficulty moving through collapsed intestinal folds (as do other capsules with active
locomotion) of an un-inflated colon.
VC (rectal pressure of ≤15mm Hg initiates insuﬄation while pressures ≥25mm Hg
terminate the introduction of gas), automated delivery of 1.9L to 4.5L (median 3.0L)
of CO2 resulted in higher distention scores when compared to a control group which
received 3.0L of manually administered CO2 (3.20L (SD, 1.16L) and 3.22L (1.12L)
for the supine and prone scanning positions, respectively, versus 2.86L (1.27L) and
3.00L (1.20L) for the case of manual insuﬄation) [33]. A statical analysis presented
by Burling indicated that increased volumes of insuﬄation did not always result in in-
creased distention scores, indicating that maximum distention and optimal distention
are in fact not identical.
In the case of traditional colonoscopy, Bretthauer et al. found that, when in-
structing endoscopists to use as little insuﬄation as possible to achieve adequate
visualization, physicians typically administered 8.3L of CO2 (range 1.2-19.8 L) com-
pared to 8.2L of air (range 1.8-18 L) with mean insuﬄation rates of 0.26 and 0.24
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L/min, for the cases of CO2 and room air, respectively. A similar study conducted
by Leung et al. found an average of 1.3 (±0.593) L of water were required to pro-
vide adequate visualization during routine colonoscopy [30]. The difference between
volumes reported by Burling, Bretthauer and Leung illustrate the vast disparity in
experimental protocols and reporting conventions that currently exist in the litera-
ture.
With the average human large intestine measuring approximately 6cm in diameter
and 1.5m is length, the total volume expected to fill a colon is on the order of 4.4L.
With Burling at el. reporting that optimal distention is slightly less than maximum
distension, their numbers regarding the volume of insuﬄating gas used during VC
seem to be on par with what one might expect. Conversely, when one considers
Bretthauer’s et al. claim that upwards of 8L of CO2 or room air might be administered
during a traditional colonoscopy, the reported value may seem unreasonably high. A
possible explanation for this discrepancy is that Bretthauer et al. were reporting
the total volumes administered, and these values do not discount volumes of gas
that are withdrawn during the course of the procedure. While studies reporting the
volumes of insuﬄation used during VC may be less than half of that used during
traditional colonsocpy, the use of pressure-regulating automated insuﬄation systems
in VC can result in a higher incidence of overdistention when compared to traditional
colonoscopy even though the latter has been reported to use twice the volume to
achieve insuﬄation. Regardless of the cause of the discrepancy between reported
volumes of insuﬄating gas, the occurrence of said discrepancies, and Burling’s at el.
observation that maximum distension is not always optimal distention, underline the
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fact that different CRC screening modalities require different levels of insuﬄation.
While a number of studies have been presented in the literature regarding the
volumes of carbon dioxide or room air that are typically needed during traditional
colonoscopy [30] and VC [33], to date, little has been published on the volumes of
gas required to enhance visualization and mobility in WCE [34, 35]. With reports
concerning the volume of gas necessary in traditional and VC showing dependence
on the type of medium used and the manner by which insuﬄation is administered,
the present investigation looks to experimentally evaluate the volumes of gas neces-
sary to enhance visualization and locomotion in WCE. In the sections that follow,
experimental procedures are described which look to assess the levels of insuﬄlation
necessary for enhancing visualization and mobility of wireless capsule endoscopes.
2.2 Enhancing Visualization
To determine the amount of fluid a capsule must carry in order to enhance visual-
ization within the colon, an ex vivo experiment was performed using porcine large
intestine. The experiment sought to quantify the effect insuﬄation has on enhancing
visualization. Once relevant levels of insuﬄation were determined, these values can
be used in conjunction with information concerning the expansion ratio produced
by various chemical reactions to determine the amount of initial volume needed to
produce a desired level of insuﬄation with a given chemical process.
In the present work, the porcine model was selected for its relative comparability
to the human GI tract. The porcine model has been used to study a number of CRC
screening modalities including active locomotion capsule endoscopy [36, 37], virtual
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Figure 2.2: The experimental setup for a feasibility test conducted to determine how
much insuﬄation is required to improve visualization within the large intestine. Ex
vivo porcine intestine was arranged in a phantom model to simulate the shape of the
human colon within the abdomen.
colonoscopy [38] and emerging endoscope platforms [32,39]. While the average length
of a human adult colon (5 m) measures roughly a quarter of that found in an adult pig
(18.5 m), when normalized with respect to weight, the anatomy of the human colon
and porcine colon become quite comparable (average adult human mass is 80kg and
average adult porcine mass is approximately 250kg). Therefore, in order to provide
for an ex vivo trial that properly reproduces conditions similar to those found in
the human colon, the porcine colon used in the following test were taken from pigs
weighing 80-100kg. For a rigorous review of the similarities and difference between
porcine and human anatomy, the interested reader is referred to [40].
The experiment used to determine the amount of insuﬄation necessary to enhance
visualization consisted of placing nine colored markers inside a section of intestine
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(a) (b) (c)
(d) (e)
0mL 50mL 200mL
450mL 1500mL
Figure 2.3: The results of the first feasibility test at different inflation increments.
(a) The intestine in its deflated state with no markers visible. (b) With just 50mL of
insuﬄation, 4 of the 9 markers became visible. (c) At 200mL, all 9 markers first come
into the field of view. (d) The threshold above which all 9 markers were consistently
visible was 450mL. (e) The intestine in its fully inflated state at 1500mL of insuﬄation.
measuring 150 cm by 6 cm in diameter. The fiducials were evenly spaced throughout
the large intestine with 3 markers placed around the inside diameter of the intestine
and this pattern being repeated twice along the length of the intestine with approxi-
mately 3cm between groups of markers (see Figure 2.3). The deflated colon was then
placed inside an anatomical model of the human torso, as shown in Figure 2.2. A
flexible endoscope (13803PKS endoscope, Karl Storz GmbH & Co. KG) was then
placed approximately 4 cm from the first set of markers in an effort to visualize the
fidicuals in a manner similar to that which might be achieved using a capsule robot. A
controlled air compressor was used to locally insuﬄate the intestine from the initially
deflated state to a state where all nine markers were consistently visible by incre-
menting the level of insuﬄation 50mL at a time. An in-line flow sensor (AWM3300V,
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Honeywell) was used to determine the volume of gas introduced into the intestine.
During the experiment, images were obtained at each volume increment imme-
diately after the level of inflation was incremented and 30 seconds later in order to
assess time-dependent effects. While appreciable time dependent behavior was not
observed, it was interesting to note the manner by which insuﬄation occurred. Rather
than gradually inflating the entire colon in a uniform manner, a small section sur-
rounding the introduction site inflatted first and then this inflation bubble grew along
the length of the colon as additional air was introduced. Table 2.1 shows the number
of markers that were visible at various levels of insuﬄation. As can be seen from the
chart, all nine markers were found to be consistently visible when 450mL of gas or
more were used to insuﬄate the sample.
Table 2.1: The number of markers visible (out of 9 total) for each inflation volume.
Above 450mL, all 9 markers were consistently visible.
Air Volume (mL) Markers Visible
0 0
50 4
100 5
150 8
200 9
250 8
300 7
350 9
400 7
450 9
1500 9
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(d) (e) (f)
0 mL 50 mL 100 mL
150 mL 200 mL 250 mL
Figure 2.4: Photos of locomotion experiment at different inflation increments. (a)
The intestine in its deflated state, where no capsule motion was possible. (b) With
just 50mL of insuﬄation, the capsule moved an average distance of 66.7mm. (c) At
100mL,the capsule moved an average distance of 150mm. (d)At 150mL, the capsule
moved an average distance of 188.3mm. (e) At 200mL, the capsule moved an average
distance of 243.3mm. (f) At 250mL, the capsule was able to move the entire length
of the colon (300mm), with an average distance of 295mm.
2.3 Enhancing Locomotion
Wireless insuﬄation offers the possibility to enhance visualization for passively loco-
moted capsule endoscopes and actively locomoted capsules alike. However, in the lat-
ter group, wireless insuﬄation may actually be necessary for the platform to function
at all. Due to the complaint nature of the GI lumen, active locomotion techniques like
magnetic guidance often have difficulty traversing the entire length of the lumen [35].
In order to assess the benefit wireless insuﬄation might have on magnetically-actuated
capsules, a second insuﬄation experiment was conducted using porcine large intestine,
a magnetic capsule, an external magnet and robotic arm.
In this second experiment a 1.21T NdFeB N35 permanent magnet (Sintered NdFeB
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magnets, B and W Technology and Trade GmbH, China) with a diameter of 60mm, a
length of 70mm and a weight of 1.5kg, was attached to the end effector of a 6 degree
of freedom Mitsubishi RV-3S serial manipulator (Mitsubishi Electric Inc.). Three
smaller internal magnets, (MTG Europe Magnet Technology Group, Germany), each
having a diameter of 3mm, a length of 10mm, and a magnetic flux density of 1.21T,
were placed inside of a pill-sized capsule (11mm diameter by 26 mm long). The
working distance between the internal and external magnets was 150mm [32]. The
robotic arm was preprogrammed to follow a straight path trajectory using Cosirop 2.0,
a Mitsubishi Electric programming platform that allows simple functions to be written
in a Basic-like language (Melfa Basic IV) and uploaded to the robotic controller by
TCP/IP communication. The trajectory was 300mm long, which approximates the
length of the longest straight portion of the colon. The robot would stop its motion
every 10mm, rotate around its Z axis (roll angle) by 10 degrees, rotate around its
Y axis (yaw angle) by 10 degrees, and then continue forward motion at a velocity
of 5mm/s. The rotational speed was between 5 and 10 degrees/s. This behavior
was performed in order to attempt to free the capsule from the deflated lumen as a
surgeon might try through teleoperation.
The magnetic capsule was placed inside fresh porcine large intestine (4mm diam-
eter), and the intestine was sealed at both ends. A 50mL syringe was connected to a
tube whose outlet was located right behind the capsule and was used to incrementally
inflate the intestine in 25mL intervals from 0mL-250mL. As shown in Figure 2.4, this
resulted in local inflation of the colon, such that the capsule could advance up until
the inflation bubble ended. Three trials were performed at each insuﬄation interval.
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Results from this set of experiments are presented in Figure 2.5.
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Figure 2.5: The distance the capsule traveled (mm) at each inflation increment.
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Chapter 3
Chemical Reactions for Insuﬄation
This chapter presents various reactions that may be used for gas generation in wireless
insuﬄation. Quantitative assements are made to determine the relative volume each
reaction might produce when initial volumes of the reactants are kept on par with
the volume of commercially available capsule endoscopes. Experimental findings are
used as a guide in the subsequent development of WCI prototypes in later chapters.
3.1 H2O2 Decomposition
Using the gas volumes reported in Chapter 2, we now determine the necessary fluid
volume required to produce each. Hydrogen Peroxide is a promising working fluid
because it can produce a large volume of gas from a small initial fluid volume. To
generate gas from H2O2, the capsule must simply pass liquid H2O2 through a catalyst
(e.g. a silver or platinum screen), which catalyzes the conversion to oxygen gas and
water.
In order to investigate the effect H2O2 concentration has on the amount of gas
generated by this exothermic process, known quanities of 30%, 50% and 70% solution
were reacted and the amount of gas generated was recorded. The experimental setup,
shown in Figure 3.1, involved a mixing flask, a holding flask, and a discharge cylinder.
The flasks were connected together with rubber tubing and were sealed with rubber
stoppers. A thermocouple was used to measure the maximum temperature of the
reaction. The catalyst used was a fine silver screen mesh, and it was cut into 11mm
circles to replicate the maximum sized screen that could fit within a swallowable
20
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Figure 3.1: Experimental setup for reacting known volumes of H2O2 to measure gas
production. A silver screen catalyst was dropped into the mixing flask which held a
small initial volume of H2O2. The gas generated displaced water in the holding flask
which was measured in a graduated cylinder.
capsule. An initial amount of Hydrogen Peroxide was placed in the mixing flask.
The catalyst was quickly dropped into the flask, and the flask was sealed. The gas
produced from this reaction was transferred to the holding flask, which held water
that was displaced up a plastic tube, through a check valve, and into a graduated
cylinder. The amount of water displaced corresponded with the approximate amount
of gas produced from the reaction. This test was performed with initial volumes
ranging from 0.5-1.25mL (in 0.25mL increments) for three concentrations of H2O2
(30%, 50%, and 70%). Initial volumes of H2O2 were measured using a graduated
syringe with graduations of 0.01mL.
To ensure repeatability, three trials were performed for each initial volume level.
One catalyst screen was used for each increment (i.e., one screen was used 3 times
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Figure 3.2: The volume of gas produced (mL) for initial amounts of liquid H2O2 at
30%, 50%, and 70% concentrations by mass.
at 0.5mL, and a new screen was used 3 times at 0.75mL). The amount of water
output was recorded and averaged over the three samples for each increment, at
each concentration, and the results are shown in Figure 3.2. The temperature on
the bottom of the holding flask was measured to provide an assessment of the heat
generated during decomposition and the maximum values recorded during each run
are presented in Figure 3.3.
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Figure 3.3: The maximum temperature recorded directly underneath the catalyst
screen during the decomposition reaction. These temperatures were usually reached
within seconds of the H2O2/catalyst interaction and were maintained during the time
required for the H2O2 to decompose.
Table 3.1: Onboard capsule fluid volumes required to produce corresponding gas
volumes from Chapter 2. The typical volume of a commercial camera pill is 2.47mL.
Gas (mL) H2O2 70% (mL) H2O2 50% (mL) H2O2 30% (mL)
50 0.2571 0.3488 0.7103
100 0.3910 0.5504 1.167
150 0.5248 0.7520 1.6233
200 0.6586 0.9536 2.0798
250 0.7925 1.1552 2.5363
300 0.9263 1.3569 2.9928
350 1.0601 1.5585 3.4492
400 1.1940 1.7601 3.9058
450 1.3278 1.9617 4.3623
1500 4.1383 6.1956 13.9487
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3.2 Acid/Base Reactions
Mild acid/base reactions offer a promising method for generating relatively large
volumes of gas using small initial volumes of reactants. In order to generate gas using
an acid/base reaction, the reactants need only be mixed in the presence of water so as
to allow their constitutive anions and cations to disassociate. While the initial volume
of the reactants directly affects the total gas generated by a given acid/base reaction,
the rate of reaction is restricted by the anions/cations, ability to disassociate. Hence,
the rate of reaction is dependent on the volume of H2O present when the reaction
takes place.
Given the desire to generate a relatively large volume of gas in a relatively short pe-
riod of time, the total volume of initial reactants must be taken into account as well as
ratio of reactant toH2O volumes. In order to investigate the use of acid/base reactions
as a gas generator for wireless capsule insuﬄation various acid/base combinations are
theoretically and experimentally evaluated. Results from these investigations are used
to select a promising acid/base combination. The use of this combination is then op-
timized by examining the effect that the initial reactant-to-H2O ratio has on rate of
reaction and total output produced, in a given time period.
In the present investigation acetic acid, citric acid, sodium bicarbonate and potas-
sium bicarbonate are examined as possible reactants in an acid/base gas generator.
These reactants give rise to four possible acid/base combinations, as is shown in Table
3.2. Given a desired total initial volume, the mass of the reactants, and the resulting
output, can be calculated based on the physical properties of the reactants, as is
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Table 3.2: Acid/Base Combinations. Clockwise, from upper left corner: A1B1 =
Acetic Acid and Sodium Bicarbonate, A2B1 = Citric Acid and Sodium Bicarbon-
ate, A2B2 = Citric Acid and Potassium Bicarbonate and A1B2 = Acetic Acid and
Potassium Bicarbonate.
Acid/base combinations and 
nu bering convention
Save printed PDF as: AcidBaseCombs
A1 A2
B1
B2
Acids
Bases
C2H4O2 C6H8O7
NaHCO3 NaHCO3
C2H4O2 C6H8O7
KHCO3 KHCO3
1 2
3 4
outlined in Appendix B.
Figure 3.4 shows the output produced within the first fifteen minutes when an
initial volume of reactants equal to 1.0mL is reacted in the presence of 0.5mL of H2O.
As can be seen in Figure 3.5, experimental results indicate that the combination of
citric acid and potassium bicarbonate results not only in the largest average output
but also the fastest rate of reaction. Figure 3.5 also shows that while citric acid and
sodium bicarbonate offer the second largest average output, acetic acid and potassium
bicarbonate offer the second fastest rate of reaction.
Based on the results presented in Figures 3.4 and 3.5 the use of citric acid and
potassium bicarbonate offers the largest average output and fastest rate of reaction
when constraints are placed on total initial volume of the reactants. In order to
determine the effect that initial water volume has on rate of reaction and total output
generated by this acid/base combination, additional experiments were preformed with
initial water to reactant volumetric ratios of .25/1.25 and .75/.75 mL per mL. Results
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Figure 3.4: Theoretical predictions and experimental observations for the output
produced by given acid/base combinations within the first fifteen minutes when an
initial volume of reactants equal to 1.0mL is reacted in the presence of 0.5mL of H2O.
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Figure 3.5: Transient output generated by various acid/base combinations when ini-
tial volumes of the reactants are set equal to 1.5mL.
from these test are presented, along with the case corresponding to an initial water
to reactant volumetric ratio of 0.5/1, in Figure 3.6.
The results presented in Figure 3.6 indicate that while the relative volume of
water present at the start of the reaction has an effect on the total output produced
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Figure 3.6: Transient output generated by citric acid and potassium bicarbonate
when initial volumes of the reactants are set equal to 1.5mL and the volumetric
water-to-reactant ratio is varied from 0.2 to 1.5.
from an initial quantity of reactants (i.e. more water in a given initial volume means
less reactants and hence less output) they also illustrate the pronounced effect this
variable has on the initial rate of reaction (i.e. the amount of output produced during
the first moments of the reaction). With an average colonoscopy taking between 30
minutes to an hour to complete [41], a wireless insuﬄation capsule should be capable
of generating the necessary volume of gas within some fraction of this time in order
to keep WCE-based colonoscopy times on par with those conducted using traditional
endoscopy. Based on the results presented in Figure 3.6 it appears as though, for a
given total initial volume, a tradeoff exist between the amount of output that can
be generated in a given time and total output that might be expected as t → ∞.
As can be seen from the data presented in Figure 3.6, a water-to-reactant volume
ratio of approximately one-half-to-one seems to offer the best compromise between
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Figure 3.7: Transient output generated by citric acid and potassium bicarbonate when
initial volumes of the reactants and water are set equal and total initial volumes are
1, 1.5 and 2mL
fast rate of reaction and total volume produced. If we redefine the examined water-
to-reactant volume ratios in terms of initial grams of citric acid per initial volume
of H2O, the data presented in Figure 3.6 is classified by dilution as 3.78, 1.51, 0.75
and 0.50 grams of citric acid per milliliter of H2O. It is interesting to note the
case corresponding to an initial water-to-reactant volume of 1-to-1 provides a level
of dilution that approximately matches reported values for the solubility of citric
acid [42].
Using the information provided in Figure 3.6, a final set of experiments was con-
ducted to determine the output generated when total initial volume is set equal to
1.0, 1.5 and 2.0mL and the water-to-reactant ratio is selected based on the results
presented in Figure 3.6. These initial volume levels were selected based on the typi-
cal size of commercially available capsule endoscopes (2.47mL) and the likely usable
volume within a capsule of said dimension. The transient output produced from said
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initial volumes are presented in Figure 3.7. The linear trend presented in Figure 3.7
was extrapolated to determine the initial volume of reactants needed to produce de-
sired volumes of CO2. Results of said extrapolation are presented in Table 3.3. Based
on the trend depicted in Figure 3.7, one might reasonably expect to obtain 450mL
from a capsule containing powdered acid and base reactants or 300mL from a capsule
containing reactants plus H2O such that the initial water-to-reactant volume ratio is
approximately one-half-to-one.
Table 3.3: Onboard capsule reactant and reactant plus water volumes required to
produce corresponding gas volumes from the insuﬄation experiment. The typical
volume of a commercial camera pill is 2.47mL.
CO2 (mL) C6H8O7 + KHCO3 (mL) C6H8O7 + KHCO3+H2O (mL)
50 0.22 0.33
100 0.45 0.67
150 0.67 1.00
200 0.89 1.34
250 1.11 1.67
300 1.33 2.00
350 1.56 2.34
400 1.78 2.67
450 2.00 3.00
1500 6.68 10.02
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Chapter 4
Wireless Insuﬄation Capsule Design
This section introduces capsule designs which were developed to demonstrate the fea-
sibility of wireless capsule insuﬄation. Preliminary efforts investigated the catalytic
decomposition of hydrogen peroxide in addition to a number of effervescent reactions
for use as possible gas generators in a WCI platform. While hydrogen peroxide was
found to have an excellent expansion ratio, recent findings published in the Journal of
Clinical Gastroenterology and Hepatology [43] have shown that even concentrations
on par with the weakest solutions presented in Chapter 2 can result in serious damage
when ingested. As such, the remainder of this work focuses on the use of effervescent
reactions for the realization of WCI. Specifically, the designs presented in this chapter
utilize citric acid (C5H8O7) and potassium bicarbonate (KHCO3) to generate carbon
dioxide (CO2). Based on the findings presented in Sections 2.2 and 2.3 we know that
one or more capsules should be capable of providing approximately 450mL to locally
enhance visualization, or, as little as 250mL to enhance locomotion in a section of
colon approximating the length of the longest straight portion of the human colon.
4.1 Acid-Base Prototype Design
Based on the specifications for relevant volumes of gas needed to enhance visualization
and locomotion within the colon, as presented in Chapter 3, two capsule architectures
are proposed. In the first concept, the capsule will carry a payload comprised only
of powdered reactants. When activated, said capsule will break apart, exposing its
contents to the fluid found in the colon. This concept allows the capsule to maximize
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achievable output by mitigating the need to carry H2O. In the second concept, the
capsule will carry one reactant in powdered form while the other will be diluted and
carried as a solution. This design will allow for the reaction to be contained within the
capsule. Throughout the remainder of this document, these two architectures will be
referred as External Reaction Capsules (ERC) and Internal Reaction Capsules (IRC),
respectively. The sections that follow present both capsule architectures in greater
detail. While the ERC has the obvious advantage of being able to transport a larger
volume of reactants for a given capsule volume, since it does not require that H2O
be carried onbaord, it does not provide the means to start and stop gas production.
Conversely, while the IRC must forfeit some internal volume to the transportation of
H2O, carrying one reactant in solution form allows metered, or throttled, control over
the rate at which reactants are mixed. Hence, the latter design sacrifices some output
in order to provide control over when output can be provided. The functionality of
initial prototypes is demonstrated in benchtop and ex vivo models.
31
Alignment pins
Bottom Shell
End Caps with slotted 
magnet housings
Save as PDF: AcidCNum4_V4b_labeled
Figure 4.1: CAD rendering of the External Reaction Capsule showing internal align-
ment features, external closing magnets and slotted magnet housings.
4.2 External Capsule Design
One elegant design of a capsule which can be remotely triggered to allow for localized
drug delivery has been recently introduced by Matesy GmbH. Their Magnetic Active
Agent Release System, or MAARS, is comprised of a weakly magnetized ferromagnetic
capsule, a 3D tracking system (3D-MAGMA) and an external magnetic field source.
The MAARS system uses a 3D tracker to localize the capsule within the GI tract and
when the capsule reaches the desired delivery site, the magnetic field source is used to
demagnetize the constitutive pieces of the capsule such that they are no longer held
together by magnetic attraction [44].
The MAARS concept looks to maximize the payload a capsule can carry by using
a ferromagnetic shell in lieu of permanent magnets paired with more conventional
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Figure 4.2: Various components of the first generation external reaction capsule show-
ing slotted magnet housing
materials. In the present work, a MAARS-like capsule is constructed using a rapid
prototyped shell (Objet30 Pro, Objet Geometries Inc. Billerica, MA) and four cylin-
drical permanent magnets. A CAD drawing of the External Reaction Capsule is
presented in Figure 4.1. The capsule consists of a four piece shell, with three pieces
defining the upper half and one piece defining the lower half. The lower half of the
capsule contains female alignment features that mate with features on the two end
caps. The end caps have additional mating features that align and constrain the up-
per center section of the capsule. An extrude cut on each end cap serves to locate a
permanent magnet. Complimentary features on the lower chamber of the capsule are
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also used to locate permanent magnets. When properly oriented and placed in said
locating features, these two sets of magnets form a magnetic link between the up-
per and lower components. The capsule can be activated by introducing an external
magnetic field strong enough to overcome the force generated by the magnetic couple
that exists between the capsule’s on-board magnets. Once said magnetic couple is
overcome, moisture is free to enter the capsule and the reaction between the acid
and base stored on-board begins. The onset of the reaction generates pressure which
serves to further open the capsule, thereby allowing the contents of the capsule to
become exposed to water found in the colon.
4.2.1 External Reaction Capsule: Ex-vivo Trials
Ex vivo trials were performed to obtain qualitative results from the reaction between
potassium bicarbonate and citric acid. As was referred to in Section 3.2, this reaction
resulted in the best solution in terms of yield of gas within the considered time interval,
from the bench tests discussed in Chapter 3. The aim of these trials is the qualitative
evaluation of colon lining visualization, as a measure of the accomplishment of the
insuﬄation. Said evaluation was carried out using the experimental setup shown in
Figure 4.3, which consisted of a heated bath, fiber-optic endoscope, image acquisition
system, and a magnetic field source for actuating the capsules.
The experiment was carried out by immersing a porcine colon in a heated bath
filled with 37oC water. The colon, measuring approximately 4cm in diameter, was
sutured to an acrylic sheet to maintain its position and orientation underwater. This
was done in order to more accurately recreate the conditions found inside a human
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Figure 4.3: Experimental setup used during ex vivo assessment of the ERC and the
IRC.
colon with respect to temperature and pressure. A pattern of nine markers serving
as fiducials, consisting of three rings of three markers each, was evenly spaced and
sutured throughout the lining of the colon. The fiducials were evenly spaced through-
out the large intestine with three markers placed around the inside diameter of the
intestine and this pattern being repeated twice along the length of the intestine with
approximately three centimeters between groups of markers, matching the layout and
placement discussed in Section 2.2. The ERC was used to carry 2mL of powdered
reactants to a location approximately 4cm past the deepest ring of markers. When
the desired location was reached, the capsule was opened using the attractive force
generated by an external magnetic field provided by a cylindrical magnet measuring
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Save as: FIG5_BFigure 4.4: Internal (above) and external (below) views of the colon prior to (left)
and following (right) activation of the capsule.
2” in length and 2” in diameter (K&J Magnetics, Product Number:DYOYO). Upon
activation, the powdered chemicals react with water within the colon to produce the
CO2 responsible for insuﬄation. Three trials of this experiment were performed by
an expert endoscopist who had previously performed more than 2,000 human clinical
endoscopy procedures.
The images presented in Figure 4.4 show that the capsule was able to insuﬄate
the section of colon to a point where most of the markers became visible. The picture
presented in the upper right of Figure 4.4 shows eight of the nine markers. Based on
the results presented in Section 2.2, this level of visibility corresponded to roughly
350mL of gas. While not all of the markers became visible during any one frame
captured by the endoscope, based on our experience with magnetic locomotion in
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section 2.3, the level of inflation is qualitatively similar to a level that would have
enabled magnetic locomotion throughout the inflated part of the colon.
During the tests, a relatively large volume of foam was generated in the colon.
The formation of foam is a natural byproduct of effervescent reactions. However,
it was interesting to note that during different runs the size of air bubbles within
the foam appeared to vary, as did the time required for said bubble to dissipate.
Figure 4.5 shows foam escaping from the ERC and obscuring the view of the colon
wall. While the ERC is not visible, the image shown in the upper right of Figure
4.4 also shows the formation of foam following activation of the capsule. With the
majority of foam staying in close proximity to the capsule, it may be possible to
activate one or more capsules at sufficient distance from the colon so as to allow
insuﬄation while retaining foam in the small intestine. Alternatively, in the sections
that follow, an Internal Reaction Capsule is presented that looks to mitigate the affect
foam production has on visualization by retaining foam within a reaction chamber
on-board the capsule.
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Figure 4.5: (left) Foam escaping the capsule and (right) obstructing the view of the
colon wall.
4.3 Internal Reaction Capsule
4.3.1 Internal Reaction Capsule: Version One
The initial prototype for the Internal Reaction Capsule (IRC) consists of rapid pro-
totyped capsule measuring 12mm OD, 10mm ID and, 32mm in length with a 1mm
thick center divider that separates the upper and lower chambers (see Figures 4.6
and 4.7). The upper chamber of the capsule houses approximately 1mL of citric
acid solution while the lower chamber is designed to hold approximately 0.64mL of
base. The magnetic ball valve uses a grade N42, 1/8” diameter, magnetic sphere
(K&J Magnetics, Inc. Model number S2). The attractive force used to keep the valve
closed is provided by magnetic coupling with a steel ring (4.173 mm OD, 1.27mm ID,
0.1mm thick) which is mounted on the opposite side of the capsule’s center divider.
The capsule is activated by introducing an external magnetic field strong enough to
unseat the magnetic sphere. Since the sphere is free to rotate in the valve seat an
external field need only be a targeted distance from the capsule to open the valve as
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Figure 4.6: Sectional view of the internal wireless insuﬄation capsule body (12mm
diameter by 32mm length), dividing wall (0.5mm thick), magnetic sphere (3.2mm
diameter) and ferromagnetic ring (4.173 mm OD, 1.27mm ID, 0.1mm thick).
the magnetic sphere will align with the orientation of the external field.
Initial benchtop testing found that the magnetic ball valve could be actuated
from a distance of approximately 6cm when using a 2” diameter by 2” thick, grade
N52, axially magnetized, permanent magnet (K&J Magnetics, Inc. Model number
DY0Y0-N52). Based on the dimensions of the capsule’s chambers, the lower cham-
ber is theoretically capable of holding 1.4g of Potassium Bicarbonate. Using the
optimal volumetric water-to-reactant ratio of 0.5 identified in Section 3.2 this mass
of potassium bicarbonate should be reacted with 0.90g of citric acid and 0.60mL of
H2O. Results presented in Section 3.2 indicate that said reactants should produce ap-
proximately 265mL of gas. Because the macroscopic density of powdered potassium
bicarbonate proved to be less than the density associated with its characteristic crys-
tal structure, in practice it was found that the initial version of the IRC was capable of
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holding approximately 0.75g of potassium bicarbonate. Following initial qualitative
assessments, it was discovered that damp, but unreacted, powder remained in the
capsule’s lower chamber long after output ceased to be generated. This may suggest
that gas generation was hampered by inadequate mixing of citric acid solution and
powdered potassium bicarbonate. In an effort to enhance mixing of the reactants, a
second IRC prototype was developed.
Figure 4.7: First generation IRC prototype (12mm diameter by 32mm length), divid-
ing wall (0.5mm thick), magnetic sphere (3.175mm diameter) and ferromagnetic ring
(3.73mm OD, 1.27mm ID, 0.01mm thick).
4.3.2 Internal Reaction Capsule: Version Two
The design of the second IRC looked to promote more efficient mixing of the powdered
base and acidic solution through the use of an additional ball valve. The prototype,
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shown in Figure 4.8, incorporated a ball valve at each end of the capsule to allow
citric acid solution to disperse through the powdered potassium bicarbonate more
evenly.
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Figure 4.8: Sectional view of the second generation Internal Reaction Capsule body
(12mm diameter by 32mm length), dividing wall, magnetic spheres and ferromagnetic
rings.
With the relative dimensions of the capsule remaining unchanged, the capsule’s
base-carrying capacity remained the limiting factor on the output of the device. When
the capsule is loaded with 0.75g of base, results presented in Section 3.2 indicate
that the resulting output should be on the order of 140mL. Benchtop tests using
the experimental setup outlined in Section 3.1 were conducted to determine if the
capsule was capable of generating such an output. During these test, the capsule was
activated in an initially dry environment. After a period of five minutes, a syringe
was used to introduce 3mL of water. This was done to allow for the initial reaction of
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the pill to be observed while also providing insight into the total output the capsule
might yield in a wet environment. When the capsule was activated in dry conditions,
the average output was 36mL (∼ 31% efficiency).
During the benchtop trials it was observed that the initial pressure spike occurring
at the start of the reaction often caused citric acid solution to be ejected from the
capsule’s upper chamber and, in some cases, powdered base was seen being ejected
from the exhaust ports of the lower chamber. When the total mass of potassium
bicarbonate in the lower chamber was reduced to 0.6 grams and 0.4grams the average
output efficiency was found to increase to 44% and 55%, respectively. This trend
seems to indicate that deceasing the relative volume of potassium bicarbonate in
the lower chamber may mitigate the loses associated with high initial pressures in
the capsule. In all cases, following the introduction of 3mL of water, the output
produced after five minutes was found to meet or exceed expected values.
Results from the current trial seem to indicate that initial pressure can cause a
loosely packed capsule to eject powdered base and/or citric acid solution. In the
presence of standing water these expelled reactants will eventually react to produce
the anticipated levels of gas. However, since much of the yield is still produced
outside the capsule, it is likely this may still result in the formation of foam within
the colon. In an effort to produce an IRC that contains the reaction within the interior
of the capsule, a third and final version of the IRC was developed. The design and
performance of said capsule is presented in the section that follows.
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Figure 4.9: Various components of second generation internal reaction capsule in-
cluding capsule body (12mm diameter by 32mm length), dividing wall (1mm thick),
magnetic spheres (3.2mm diameter) and ferromagnetic rings (4.173 mm OD, 1.27mm
ID, 0.1mm thick).
4.3.3 Internal Reaction Capsule: Version Three
The third generation of the IRC looks to mitigate the problems seen in previous ver-
sion regarding initial pressures causing reactants to be ejected from the capsule. The
current design attempts to accomplish said task by confining the magnetic spheres,
which are used as ball valves, within separate chambers so as to allow them both to
be reseated upon removal of the valve-actuating external field. A CAD rendering of
the devise is shown in Figure 4.10. It is hypothesized that this action will allow flow
within the capsule to be throttled in a manner that allows the initial pressure spike to
be controlled. Additionally, where previous versions of the device had exhaust ports
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Figure 4.10: Sectional view of the third generation Internal Reaction Capsule body
(12mm diameter by 32mm length), dividing wall (1mm thick), magnetic spheres
(3.175mm diameter) and ferromagnetic rings, not shown (3.73mm OD, 1.27mm ID,
0.01mm thick).
in a radial pattern around the radius of the lower chamber of the capsule, the current
design has exhaust ports located along the upper edge of the lower chamber. It is
thought that this change in placement will help keep the powdered contents of the
lower chamber within the capsule since avenues of escape are now located above said
powdered contents rather than below.
The output produced by the current design was assessed using the benchtop setup
described in Section 3.1. During these trials the capsule was loaded with 0.8 grams of
potassium bicarbonate and 0.9mL of citric acid solution having a mass concentration
of 1.5g/mL. In each trial, the capsule was activated in a dry 25mL flask and allowed
to react for a period of five minutes. At that time, 3mL of room temperature H2O
were injected into the flask to mimic the moist environment of the colon. The output
generated during the test was recorded at one minute intervals. As can be seen
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Figure 4.11: Components (left) of third generation Internal Reaction Capsule body
(12mm diameter by 32mm in length), dividing wall (1mm thick), magnetic spheres
(3.175mm diameter) and ferromagnetic rings, not shown (3.73mm OD, 1.27mm ID,
0.01mm thick) and assembled device (right).
in Figure 4.12, output from the devices seems to reach a plateau at approximately
90mL as the five minute mark is approached. Following the introduction of H2O in
the reaction flask, the rate at which gas is produced is seen to initially increase and
a new plateau is approached around the 150mL level. While total output produced
by the third generation capsule is similar to that observed for the second generation
capsule, the output generated prior to the introduction of the H2O was found to be
approximately twice the volume produced by the second generation design.
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Figure 4.12: Transient output produced by third generation internal reaction capsule
with average initial mass of potassium bicarbonate equal to 0.8 grams and an initial
volume of 0.9mL of citric acid solution having a mass concentration of 1.5g/mL.
4.3.4 Internal Reaction Capsule: Ex-Vivo Trials
In order to assess feasibility of the IRC, two ex-vivo trials we undertaken. In both
trials, the experimental setup shown in Figure 4.3, and described in Section 4.2.1, was
used. In the first trial, a single capsule was placed approximately ten centimeters past
the ring of markers furthest from the rectum. A robot arm was then used to position
an external permanent magnet, in order to activate the capsule. The robotic arm was
equipped with an ATI Mini 45 load cell to allow for force-control based manipulation
of the magnet’s location and orientation. In order to limit the displacement caused by
the magnetic link between external permanent magnet and those used on-board the
capsules, a thin piece of acrylic (approximately 3mm in thickness) was placed on top
of the heated bath. During the trials, an endoscope (Karl Storz) was used to observe
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IRC_Single Capsule Result ~2mins after 
activation
Save as PDF: IRC_SingleCapsule_Result_After_2minFigure 4.13: Endoscopic view (left) and xternal view (right) demonstrating the level
of insuﬄation provided by a single third generation IRC approximately two minutes
after activation.
the level of insuﬄation provided by the device and the amount of foam produced.
The images presented in Figure 4.13 were taken approximately two minutes after the
IRC was activated. As can be seen in the figure, the capsule was successful in locally
inflating a section of colon measuring approximately 5.5 inches in length by one and a
quarter inches in diameter. The figure also shows that foam generated by the capsule
did not hamper the ability to view the colon lining in the area directly surrounding
the capsule.
In the second trial, three capsules were placed approximately ten centimeters past
the ring of markers furthest from the rectum. Once again, a robotic arm equipped
with a axially-magnetized cylindrical end-effector was used to activate the capsules
by simply passing over the length of the colon while remaining roughly four inches
above the water level of the heated bath. Figure 4.14 shows an image taken with the
endoscope (left) and an exterior view of the colon (right) that were taken approxi-
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Figure 4.14: Endoscopic view (left) and external view (right) demonstrating the level
of insuﬄation provided by three third generation IRC’s approximately one minute
after activation.
mately one minute after the initial activation. As can be seen in the figure, one of the
capsules has been pulled away from the other two by the magnetic force developed
during the initial activation. While a small amount of foam can be seen exiting the
capsule, the image demonstrates that after as little as one minute the capsules were
able to provide enough insuﬄation to allow for visualization of six markers, and two
capsules, disbursed over a section of colon measuring approximately five inches in
length.
Approximately three minutes after the initial activation, the external permanent
magnet was used to activate the capsules once again. During this event, the magnetic
attraction developed between various components in the system caused the three
capsules to come together between the second and third rings of markers. Figure
4.15 shows the capsules being held against the upper side of the colon wall and
the foam produced by the reaction during this dynamic event. Figure 4.16 provides
interior and exterior images of the colon taken approximately two minutes after the
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Figure 4.15: Endoscopic view (left) and external view (right) during a secondary
activation of three IRCs approximately two minutes after an initial activation during
the same ex vivo trial
Figure 4.16: Endoscopic view (left) and external view (right) demonstrating the level
of visualization provided by three third generation IRCs approximately one minute
after a secondary activation.
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second activation of the capsules. As can be seen in the figure, approximately five
minutes after the initial activation, and two minutes after a subsequent activation,
visualization within the colon has been greatly enhanced. This demonstrates that
even after a dynamic triggering of the capsules, potassium bicarbonate and citric acid
can be used to provide foam-free enhancement of both visualization and locomotion
within the colon.
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Chapter 5
Discussion
Insuﬄation has a two-fold clinical value in capsule endoscopy. First, it has the poten-
tial to enhance visualization, especially in larger lumens such as the colon. Second,
it can ease the passage of active locomotion capsules, whether they be actuated by
externally applied magnetic fields or other methods, such as legs, when they might
otherwise be impeded by deflated intestinal folds. As shown in this study, even a small
amount of insuﬄation substantially increases the surface area of the intestine that is
visible to the capsule since gases tend to form a local bubble of inflated intestine close
to the source of insuﬄation. This enhanced visualization could improve a capsule en-
doscope’s sensitivity for detecting colonic polyps, advanced adenomas, and colorectal
cancer, which is currently relatively low compared to traditional colonoscopy. While
results show it is possible to carry a sufficient volume of reactants onboard a single
capsule to locally enhance visualization and locomotion, one can easily envision how
such a capsule could be used as part of a multiple capsule solution similar to the
three inflation capsules plus camera experiment in Chapter 4. In such a system, one
or more capsules could provide insuﬄation while other capsules are used to acquire
images, provide diagnostic functions, or deploy therapeutic intervention.
5.1 Choice Of Working Reaction
The present work has presented a wireless system to inflate the colon through the use
of a biocompatible chemical reaction. The proposed solution entails the use potassium
bicarbonate and citric acid. The achieved volume of gas has been found sufficient to
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distend the colon lumen. This inflation produces a tangible enhancement of colon
lining visualization. While not presented in this work, not yet published preliminary
experiments indicate that, environmental conditions have marked effect on the yield of
gas. Temperature is particularly important, since it enhances chemical solubility and
reaction kinetics. In fact, an incremental yield of 26.6% and 33.96% has been found
for the reactions with potassium bicarbonate and sodium bicarbonate, respectively,
when comparing room temperature gas generation with the yield obtained at 37oC.
In the present work, carbon dioxide is the product responsible for inflation. This
gas is easily absorbed through the internal mucosa into the blood, and its use avoids
overdistention and post-procedure abdominal discomfort [45]. The reaction between
potassium bicarbonate and citric acid has been found to generate the largest output.
However, this reaction produces potassium citrate and should therefore not be used in
cases of patients presenting with kidney failure or urinary infection. In such cases, the
reaction with sodium bicarbonate should be used since potassium citrate or potassium
bicarbonate absorbed by the colon [46] could aggravate these conditions.
While the results presented in this work indicate that the reactions used have the
potential to obscure a capsule endoscope’s view of the colon due to the production of
foam, one can envision a scenario where said foam is used to disperse dyes in a manner
akin to chromoendoscopy [47]. Chromoendoscopy is the practice of using adsorptive,
contrast or reactive chemical agents to provide greater contrast between healthy tis-
sue and abnormalities. In the case of capsule based endoscopy, the reactants could be
premixed with indigo carmine to allow an IRC to release dye-infused foam throughout
the colon prior to inspection with a WCE. Studies concerning the clinical relevance
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of chromoendoscopy have reported site-dependent results, indicating that the tech-
nique may depend considerably on the operator [47]. It therefore stands to reason
that incorporating chromoendoscopy in a robotic-based WCE platform could remove
operator dependencies and provide the advantage associated with chromoendoscopy
to a larger number of patients.
5.2 Capsule Design
While the present work has presented four capsule designs, these prototypes represent
a body of knowledge that was gained during the design and fabrication of more than
fifty unique designs. Many of the preliminary capsules, which have not been included
in this work for brevity, incorporated the use of custom microcontrollers, commer-
cially available valves and reed switches, precision machined components, and state-
of-the-art power supplies. While the design and fabrication of said capsules provided
ample opportunity to demonstrate technical prowess, benchtop testing proved time
and again that simpler systems outperformed their more complex counterparts. A
likely reason for these findings can be found in the inherent limitations imposed by
current 3D printing technology. While the systems used during this work are capa-
ble of printing features less than half a millimeter in principal dimension, features
on this scale are often hard to post process after they are printed and their limited
surface area makes adhesion challenging even when working with epoxies specifically
formulated for use with the types of polymers that are used by 3D printers.
One example of an early prototype which incorporates electromechanical activa-
tion and precision fabrication is presented in Figure 5.1. In theory, this hydrogen
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peroxide based insuﬄation capsule could be activated by a physician by simply using
a magnet to close a magnetic reed switch. When the reed switch is closed, current
from the battery flows through a high resistance wire. The heat generated by the
resistive load serves to melt a paraffin wax plug. Prior to heating, this plug is used to
restrain the forward motion of the system’s catalyst containment sled as it is being
acted on by the force of a compressed spring. When the wax is heated to a point
where it’s shear strength can no longer support the load provided by the spring,
the catalyst containment sled translates forward. While the catalyst containment
sled cover prevents hydrogen peroxide from entering the catalyst containment sled
prior to activation, following the translation, flow in and out of the containment sled
is unimpeded and the reaction commences. While hydrostatic tension prevents hy-
drogen peroxide from escaping the pill, once the hydrogen peroxide is converted to
oxygen, it is free to pass through said holes so it may inflate the colon.
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Figure 5.1: Early electromechanical H2O2 capsule prototype.
Realization of the design shown in Figure 5.1 requires a number of engineering
skill sets. Sizing of the paraffin wax support requires a working knowledge of me-
chanics of materials. Ensuring that the resistive heater can melt the paraffin wax
requires insight into passive electronics and heat transfer. Maximizing the design’s
fluid carrying capacity can be achieved by minimizing the volume required of internal
structures with the aid of finite element analysis. All of these skills were utilized in
the development of the capsule. Despite the number of technical hurdles that were
overcome to realize said design the challenges presented by reliably sealing the cham-
bers containing electrical components, and the two halves of the capsule, proved to
be nontrivial, to say the least. In an effort to overcome these challenges, subsequent
variations of this concept employed magnetic components in lieu of electromechanical
components since the former can be exposed to hydrogen peroxide without fear of
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failure. An example of a magnetic-based insuﬄation capsule which arose from the
lessons learned during early electromechanical designs is presented in Figure 5.2.
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Figure 5.2: Early magnetic H2O2 capsule prototype.
Figure 5.2 shows a magnetic-based insuﬄation capsule. In said concept, hydrogen
peroxide is stored in the body of the capsule while a small chamber within the capsule
is used to house the catalyst. The capsule is triggered by using an external magnet to
induce a force on an internal magnet which is attached to the catalyst chamber. This
force causes the catalyst chamber to be translated into the center of the capsule where
the catalyst is exposed to the hydrogen peroxide within the body of the capsule. This
concept eliminates the need for electronic components and thereby mitigates issues
associated with insulating said components from fluids within the capsule. That
said, the geometry associated with the catalyst containment sled and the tolerances
associated with the rapid prototyping system made it difficult to achieve effective
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sealing between the catalyst containment chamber and the interior of the capsule
when attempting to execute this concept. Subsequent concepts overcame this sealing
challenge by employing flat-on-flat interfaces for sealing surfaces. An example of such
a design is given by Figure 5.3.
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Figure 5.3: Picture (left) and cad rendering (right) of a revised magnetic H2O2 capsule
concept demonstrating flat-on-flat valve sealing.
The capsule shown in Figure 5.3 uses a small catalyst containment chamber, two
internal magnets and simple interface geometry to ensure reliable valve seating capa-
ble of withstanding the aggressive nature of high concentration hydrogen peroxide.
While the final design of the IRC used a single spherical magnet paired with a ferro-
magnetic ring to provide the necessary sealing force, the original IRC concept utilized
the style of valve shown in Figure 5.3. While the flat-on-flat valve design allows for
reliable and robust valve seating due to the high tolerances that can be achieved
when manufacturing such simple geometry, the valve design utilized in versions of the
IRC presented in Chapter 4 looked to maximize the volume available of reactants by
minimizing the volume required for internal structures. Hydrogen peroxide based in-
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suﬄation capsule designs were not presented in Chapter 4, nor were ex-vivo trials ever
undertaken, due to the health risk associated with such a reactive solution, however,
it is worth noting that many of the design features ultimately incorporated in the
acid/base prototypes were derived from lessons learned while exploring the feasibility
of H2O2 based WCI.
The extensive number of design iterations undertaken during this work served
to highlight a number of design principles which proved particularly advantageous
when developing capsule based devices. Paramount amongst said principles is the
need to keep designs as simple as possible. While it may be natural for an engineer
to want to display as many of their technical competencies as possible in a given
design, the volume restrictions placed on capsule endoscopy leaves little room for
showing off. A number of very impressive capsules have been developed through
the use of advanced design and machining however, the complexity associated with
such capsules severely limits the likelihood of reaching mass markets. Furthermore,
reducing the complexity of a capsule often allows for enhanced functionality. In the
case of WCI this lesson is exemplified by the increases in reactant volume which can
be obtained by eliminating the need for electronics, power supplies, and the housing
structures that would otherwise be necessitated by said components.
The other design principles elucidated during the extensive number of design it-
erations undertaken during this work build on the concept of simplicity. While post
processing and assembly may require a design to broken down into a number of differ-
ent pieces, whenever possible, the total number of pieces utilized in a given assembly
should be kept to a minimum. Inevitably, each piece in an assembly will need to
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be contained within the assembly. While this may be accomplished with the use of
adhesives or kinematically inspired design features, incorporation of either will un-
doubtedly require greater volume than might otherwise be used if the component
were integrated into a larger structure. As previously stated, post processing, and in
some cases assembly, will place limitations on the number of features that can be con-
solidated into a given structure, so one should try to remain mindful of the cost and
benefits associated with breaking a larger structure down into smaller constitutive
components.
Finally, while the capabilities of modern 3D printers allow for the fabrication
of astonishingly small components, the effort required for the post processing and
assembly of such components is often inversely related to their scale. This provides yet
another reason to consolidate smaller components into larger sub-assemblies whenever
possible.
5.3 Future Work
During the present work it was observed that the macroscopic density of the powdered
reactants was about half of the manufacturer’s stated density. While efforts were
made to compact powdered reactants as they were being loaded into the capsules,
future work will investigate the use of hydraulic compaction to obtain densely packed
reactants in a form factor matching that of the capsule’s inner chambers. It is thought
that such a technique will allow for greater yields by increasing the mass of reactants
that can be loaded into a given volume and by reducing the likelihood of reactants
being ejected from the capsule during periods of high internal pressure.
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Magnetic valve design presents another area for future research. In the present
work, the IRC employed the use of magnetic spheres and ferromagnetic rings to
produce a ball valve capable of being actuated by an external magnetic field source.
While the valves were found to operate sufficiently to provide for a proof of concept,
several aspects of the valve could be optimized for the benefit of future designs.
During testing, it was noted, the citric acid solution used by the IRC produced a
sticky film that caused the valves to become stuck in the open position after repeated
use. Future designs will investigate the use of anti-stick coating to prevent this action.
In the case of pairing WCI with magnetic-based active locomotion, the magnetic
ball valve within the insuﬄation capsule should be designed such that an active cap-
sule can be maneuvered past an insuﬄation capsule without resulting in a magnetic
couple that is strong enough to cause the two to become linked. This could be ac-
complished by sizing the moving magnet within the insuﬄation capsule such that the
force generated between it and other magnetic field sources within the system is less
than the weight of the insuﬄation capsule. In such a case, an active capsule could
be moved along the upper side of the colon wall while insuﬄation capsules lay on the
lower surface.
The exhaust ports utilized in the IRC also represent a design feature which could
be optimized in future iterations. In the final IRC design the exhaust ports were
moved to the upper edge of the powdered reactant chamber in an effort to prevent
said reactant from being expelled from the chamber by high initial pressures. Another
method that could enhance flow through the capsule while retaining reactants within
may be realized through the uses of a hydrophobic coating around the exhaust ports in
60
the upper chamber of the capsule. While the polypropylene-like material the current
prototypes were constructed of renders the capsules hydrophilic, the upper chamber
of the capsules could be treated with a hydrophobic coating, like paraffin wax, such
that small openings in the capsule’s shell would allow gases to exit the capsule while
providing resistance to passing liquids.
Future work will also look to assess the system’s performance in an animal-based
in vivo model. While the use of a porcine model for said purposes will not take
into account the challenges that may be presented by haustral folds, it will certainly
provide a preliminary proof-of-concept in an in vivo setting. Subsequent animal and
human trials will require comparison with standard colonoscopy, to quantitatively
assess the effectiveness of WCI when acting as part of modular capsule endoscopy
platform.
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Appendix A
H2O2 Decomposition
The decomposition of H2O2 to produce dioxygen and water is given by
2H2O2 → 2H2O +O2 (A.1)
showing that each mole of H2O2 decomposes to produce two moles of water and half a
mole of dioxygen. Given a desired initial volume of H2O2, the mass of H2O2 solution
needed, for a given concentration, is given by
Vtot = X ∗ (wH2O2 ∗
1
ρH2O2
+ (1− wH2O2) ∗
1
ρH2O
) (A.2)
Where wH2O2 is the mass fraction of hydrogen peroxide in the solution, i.e. the mass
of hydrogen peroxide divided by the total mass of the solution. The total mass of the
solution is denoted by X and the mass of H2O2 found in the solution is given by
mH2O2 = X ∗ wH2O2 (A.3)
and the total number of H2O2 moles is given by
MolH2O2 =
mH2O2
MMH2O2
(A.4)
As previously stated, one mole of H2O2 decomposes to form two moles of H2O and
half a mole of O2. Therefore, if we estimate the volume of gas produced by setting
it equal to the volume occupied by a given number of O2 moles, the volume of gas
generated is given by
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Figure A.1: Output generated as a function of time when decomposing 1mL of 70%
H2O2 using approximately 0.5 mL of iridium .
Vgenerated =
1
2
MolH2O2 ∗
MMO2
ρO2
(A.5)
For the case of 1mL of 70% H2O2, this model predicts an output of approximately
316.042mL when using the molar mass and density of dioxygen as given in Table B.1.
As can be seen from the results presented in Figure A.1 when 1mL of 70% H2O2 is
decomposed using a small volume of iridium pellets the modeled and experimental
results find good agreement.
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Appendix B
Acid-Base Reactions
Acids and bases are commonly defined by the cation and anion they produce in the
presence of water. When acids are added to water they produce hydrogen ions, H+,
while bases produce hydroxide ions, OH−, in the presence of water. While acids
react with some metals to produce hydrogen, H2 , they also react with compounds
containing CO2−3 to form water and carbon dioxide. Given the biocompatibility of
this latter group of products, their use will be investigated in the present work.
In order to estimate the amount of gas a given acid/base reaction may generate
we can start by determining the number of moles of each that could be delivered in
a capsule of known volume.
Vtot = Xmolesacid ∗ MMa
ρa
+ Ymolesbase ∗ MMb
ρb
(B.1)
Where Vtot is the total volume available for reactants. The molecular mass of the
acid and base are given by MMa and MMb, respectively. The density of the acid and
base are given by ρa and ρb, respectively.When the ratio of acid moles to base moles
is known, equation B.1 can be rewritten as
Vtot = Xmolesacid(
MMa
ρa
+R ∗ MMb
ρb
) (B.2)
where R = Ymolesbase/Xmoleacid. The value of R can be determined by balancing
the number of hydrogen ions, H+, and hydroxide ions, OH−, present in the initial
reactants and the mass of the initial reactants can then be determined by
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massa = MMa
Vtotρaρb
MMaρb +MMbRρa
(B.3)
and
massb = MMbR
Vtotρaρb
MMaρb +MMbRρa
(B.4)
If we specify a generic acid structure as HA, where A− is an anion, and a generic
base structure as BOH, where B+ is an appropriate cation, then, in generic terms,
an acid/base reaction can be give as
H+ + A+B +OH− → A+B +H2O (B.5)
where H2O often results due to the highly favorable bonding configuration offered
by H+ + OH−. This pair occurs stoichiometricly when the number of H+ cation
produced by the dissociation of HA compounds matches the number of OH− anions
result from the dissociation of BOH compounds. The nature of the initial HA and
BOH structures will therefore have an effect on the ratio needed for stoichiometric
production of H2O, and hence CO2. As an example, consider the familiar vinegar
and baking soda volcano. Otherwise known as an acetic acid and sodium bicarbonate
volcano.
When acetic acid, CH3CO2H, and sodium bicarbonate, NaHCO3, are dissolved
in water, they disassociate to form an acetate ion and a hydrogen ion (C2H3O
−
2 +
H+) and a sodium ion, carbon dioxide and a hydroxide ion (Na+ + CO2 + OH
−),
respectively. These reactants result in the production of sodium acetate, water and
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carbon dioxide. With a mole-to-mole ratio of unity, this reaction is given by
CH3COOH +NaHCO3 → CH3COO− +H+ +Na+ + CO2 +OH− (B.6)
→ CH3COONa+ CO2 +H2O (B.7)
and equation B.2 becomes
Xmolesacid =
Vtot
(MMa
ρa
+ MMb
ρb
)
(B.8)
Since the number of moles of CO2 produced by this reaction is equal to the number
of moles of base initially provided, the volume of the volume of CO2 produced is given
by
VCO2 =
Vtot
(MMa
ρa
+ MMb
ρb
)
MMCO2
ρCO2
(B.9)
If we turn our attention to the less ubiquitous citric acid and sodium bicarbonate
reaction, we see that citric acid disassociates into a citric acid ion (C6H5O
−3
7 ) and
three hydrogen ions (3H+). When this solution is reacted with sodium bicarbonate
they must be mixed in a 3-to-1 molar ratio since each sodium bicarbonate molecule
will disassociate to from only one hydroxide ion. This process, which results in the
production of sodium citrate (C6H5Na3O7), carbon dioxide (CO2) and water (H2O),
is given by
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C6H8O7 + 3NaHCO3 → C6H5O−37 + 3H+ + 3Na+ + 3CO2 + 3OH− (B.10)
→ C6H5Na3O7 + 3CO2 + 3H2O (B.11)
While the preceding examples illustrate how the structure of the acid molecule
will have a direct effect on the number of CO2 moles produced, this model does not
account for the effect that properties such as density, solubility and heat of forma-
tion have on the total volume of the products. Given these unaccounted variables,
experimental results are used to validate the response of the model for all possible
acid/base combinations arising from the use of acetic and citric acid and sodium bi-
carbonate and potassium bicarbonate. Having determined the proper molar ratio for
reacting acetic acid with sodium bicarbonate, and citric acid with sodium bicarbon-
ate, we now look to determine the proper ratio for stoichiometrically reacting acetic
acid with potassium bicarbonate and citric acid with potassium bicarbonate.
When potassium bicarbonate is dissolved in water it disassociates to form a potas-
sium ion (K+), carbon dioxide (CO2) and a hydroxide ion (OH
−). Due to the pro-
duction of a single hydroxide ion per molecule of potassium bicarbonate, this base
can be reacted in a one-to-one molar ratio with acetic acid, to give
CH3COOH +KHCO3 → CH3COO− +H+ +K+ + CO2 +OH− (B.12)
→ CH3COOK + CO2 +H2O (B.13)
or, it can be reacted in a three-to-one molar ratio with citric acid to give
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C6H8O7 + 3KHCO3 → C6H5O−37 + 3H+ + 3K+ + 3CO2 + 3OH− (B.14)
→ C6H5K3O7 + 3CO2 + 3H2O (B.15)
As can be seen from inspection of equations B.6-B.7 and B.10-B.15 in the case
of acetic acid being reacted with the given bases, one mole of acid results in one
mole of CO2, while in cases when citric acid is used, one mole of acid results in
three moles of CO2. Given the molecular masses and densities listed in Table B.1,
the expected volumes produced from given initial reactant volumes can be calculated
using equation A.9 along with the proper molar ratio, R. Results produced by the
model are shown in Figure B.1.
Figure B.1: Theoretical output from selected acid/base combinations
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B.1 Reactant And Product Properties
Table B.1: Physical properties of various reactants and products at NTP
Chemical Molecular Mass (g/mol) Density (g/mL)
Acetic Acid 60.05 1.049
Citric Acid 192.12 1.665
Sodium Bicarbonate 84.01 2.2
Potassium Bicarbonate 100.115 2.17
Carbon Dioxide 44.01 1.842 ∗ 10−3
dioxygen 32 1.331 ∗ 10−3
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